Trial intelligence / Profile preview

MED2005 for Erectile Dysfunction

NCT03813992Phase 3Completed

Sponsor
Futura Medical plc
Start
Nov 2018
Primary completion
Jul 2019
Modality
Hydrogel Systems, Small Molecules
Countries
9
01

Overview

Phase 3, randomised, double-blind trial of MED2005 in erectile dysfunction (ED) (4 arms), sponsored by Futura Medical plc. Primary endpoints: International Index for Erectile Function - Erectile Function Domain, Sexual Encounter Profile Question 2 and 1 more. Started Nov 2018; status: completed.

02

Drugs

MED2005
03

Conditions

erectile dysfunction (ED)

Beyond the preview

Go deeper on NCT03813992.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03813992.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call